nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—Lisdexamfetamine—Lisinopril—systemic scleroderma	0.531	1	CrCrCtD
Phenelzine—CYP2C8—Mometasone—systemic scleroderma	0.0987	0.422	CbGbCtD
Phenelzine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0409	0.175	CbGbCtD
Phenelzine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0393	0.168	CbGbCtD
Phenelzine—CYP2C19—Prednisone—systemic scleroderma	0.0263	0.113	CbGbCtD
Phenelzine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0159	0.0681	CbGbCtD
Phenelzine—CYP3A4—Prednisone—systemic scleroderma	0.0127	0.0545	CbGbCtD
Phenelzine—AOC3—endothelium—systemic scleroderma	0.00607	0.123	CbGeAlD
Phenelzine—AOC3—blood vessel—systemic scleroderma	0.0056	0.113	CbGeAlD
Phenelzine—GPT2—connective tissue—systemic scleroderma	0.0033	0.0669	CbGeAlD
Phenelzine—GPT—tendon—systemic scleroderma	0.00297	0.0602	CbGeAlD
Phenelzine—AOC3—connective tissue—systemic scleroderma	0.00287	0.0581	CbGeAlD
Phenelzine—AOC3—smooth muscle tissue—systemic scleroderma	0.00263	0.0532	CbGeAlD
Phenelzine—GPT2—digestive system—systemic scleroderma	0.00239	0.0483	CbGeAlD
Phenelzine—GPT2—tendon—systemic scleroderma	0.00227	0.046	CbGeAlD
Phenelzine—AOC3—digestive system—systemic scleroderma	0.00207	0.042	CbGeAlD
Phenelzine—GPT2—lung—systemic scleroderma	0.00199	0.0404	CbGeAlD
Phenelzine—AOC3—tendon—systemic scleroderma	0.00197	0.04	CbGeAlD
Phenelzine—AOC3—lung—systemic scleroderma	0.00173	0.0351	CbGeAlD
Phenelzine—ABAT—tendon—systemic scleroderma	0.00167	0.0338	CbGeAlD
Phenelzine—ABAT—lung—systemic scleroderma	0.00146	0.0296	CbGeAlD
Phenelzine—MAOB—connective tissue—systemic scleroderma	0.00118	0.0239	CbGeAlD
Phenelzine—MAOA—connective tissue—systemic scleroderma	0.00101	0.0204	CbGeAlD
Phenelzine—MAOB—digestive system—systemic scleroderma	0.000853	0.0173	CbGeAlD
Phenelzine—MAOB—tendon—systemic scleroderma	0.000811	0.0164	CbGeAlD
Phenelzine—CYP2C19—digestive system—systemic scleroderma	0.000743	0.0151	CbGeAlD
Phenelzine—MAOA—digestive system—systemic scleroderma	0.000727	0.0147	CbGeAlD
Phenelzine—MAOB—lung—systemic scleroderma	0.000712	0.0144	CbGeAlD
Phenelzine—Jaundice—Mycophenolic acid—systemic scleroderma	0.000706	0.0038	CcSEcCtD
Phenelzine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00379	CcSEcCtD
Phenelzine—Insomnia—Pentoxifylline—systemic scleroderma	0.000701	0.00377	CcSEcCtD
Phenelzine—Nervousness—Captopril—systemic scleroderma	0.000699	0.00376	CcSEcCtD
Phenelzine—Sweating—Mycophenolic acid—systemic scleroderma	0.000694	0.00373	CcSEcCtD
Phenelzine—MAOA—tendon—systemic scleroderma	0.000692	0.014	CbGeAlD
Phenelzine—Somnolence—Pentoxifylline—systemic scleroderma	0.000689	0.00371	CcSEcCtD
Phenelzine—Dry mouth—Mometasone—systemic scleroderma	0.000682	0.00367	CcSEcCtD
Phenelzine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000682	0.00367	CcSEcCtD
Phenelzine—Vision blurred—Captopril—systemic scleroderma	0.000678	0.00365	CcSEcCtD
Phenelzine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.000677	0.00364	CcSEcCtD
Phenelzine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.000674	0.00362	CcSEcCtD
Phenelzine—Ill-defined disorder—Captopril—systemic scleroderma	0.000668	0.00359	CcSEcCtD
Phenelzine—Weight increased—Lisinopril—systemic scleroderma	0.000666	0.00358	CcSEcCtD
Phenelzine—Constipation—Pentoxifylline—systemic scleroderma	0.000663	0.00356	CcSEcCtD
Phenelzine—Malaise—Captopril—systemic scleroderma	0.000649	0.00349	CcSEcCtD
Phenelzine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000639	0.00344	CcSEcCtD
Phenelzine—Jaundice—Lisinopril—systemic scleroderma	0.000636	0.00342	CcSEcCtD
Phenelzine—Sweating—Lisinopril—systemic scleroderma	0.000625	0.00336	CcSEcCtD
Phenelzine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000613	0.0033	CcSEcCtD
Phenelzine—MAOA—lung—systemic scleroderma	0.000607	0.0123	CbGeAlD
Phenelzine—Discomfort—Captopril—systemic scleroderma	0.000605	0.00326	CcSEcCtD
Phenelzine—Paraesthesia—Mometasone—systemic scleroderma	0.000601	0.00323	CcSEcCtD
Phenelzine—Dry mouth—Captopril—systemic scleroderma	0.000599	0.00322	CcSEcCtD
Phenelzine—Euphoric mood—Prednisone—systemic scleroderma	0.000595	0.0032	CcSEcCtD
Phenelzine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00317	CcSEcCtD
Phenelzine—Dyspepsia—Mometasone—systemic scleroderma	0.000589	0.00317	CcSEcCtD
Phenelzine—CYP3A5—digestive system—systemic scleroderma	0.000585	0.0119	CbGeAlD
Phenelzine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00314	CcSEcCtD
Phenelzine—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000583	0.00313	CcSEcCtD
Phenelzine—Shock—Captopril—systemic scleroderma	0.000578	0.00311	CcSEcCtD
Phenelzine—Fatigue—Mometasone—systemic scleroderma	0.000577	0.0031	CcSEcCtD
Phenelzine—Tachycardia—Captopril—systemic scleroderma	0.000573	0.00308	CcSEcCtD
Phenelzine—Malaise—Azathioprine—systemic scleroderma	0.000566	0.00305	CcSEcCtD
Phenelzine—Leukopenia—Azathioprine—systemic scleroderma	0.000562	0.00302	CcSEcCtD
Phenelzine—Vision blurred—Leflunomide—systemic scleroderma	0.000559	0.00301	CcSEcCtD
Phenelzine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000557	0.003	CcSEcCtD
Phenelzine—Asthenia—Pentoxifylline—systemic scleroderma	0.000556	0.00299	CcSEcCtD
Phenelzine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00055	0.00296	CcSEcCtD
Phenelzine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00055	0.00296	CcSEcCtD
Phenelzine—Pruritus—Pentoxifylline—systemic scleroderma	0.000548	0.00295	CcSEcCtD
Phenelzine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.000548	0.00295	CcSEcCtD
Phenelzine—CYP2E1—digestive system—systemic scleroderma	0.000546	0.0111	CbGeAlD
Phenelzine—Malaise—Leflunomide—systemic scleroderma	0.000535	0.00288	CcSEcCtD
Phenelzine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000533	0.00287	CcSEcCtD
Phenelzine—Insomnia—Captopril—systemic scleroderma	0.000531	0.00286	CcSEcCtD
Phenelzine—Leukopenia—Leflunomide—systemic scleroderma	0.000531	0.00286	CcSEcCtD
Phenelzine—Tremor—Mycophenolic acid—systemic scleroderma	0.00053	0.00285	CcSEcCtD
Phenelzine—Coma—Methotrexate—systemic scleroderma	0.000529	0.00284	CcSEcCtD
Phenelzine—Body temperature increased—Mometasone—systemic scleroderma	0.000529	0.00284	CcSEcCtD
Phenelzine—Discomfort—Azathioprine—systemic scleroderma	0.000528	0.00284	CcSEcCtD
Phenelzine—Paraesthesia—Captopril—systemic scleroderma	0.000527	0.00284	CcSEcCtD
Phenelzine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000525	0.00282	CcSEcCtD
Phenelzine—Somnolence—Captopril—systemic scleroderma	0.000522	0.00281	CcSEcCtD
Phenelzine—Agitation—Mycophenolic acid—systemic scleroderma	0.00052	0.0028	CcSEcCtD
Phenelzine—CYP2E1—tendon—systemic scleroderma	0.00052	0.0105	CbGeAlD
Phenelzine—Dyspepsia—Captopril—systemic scleroderma	0.000517	0.00278	CcSEcCtD
Phenelzine—Dizziness—Pentoxifylline—systemic scleroderma	0.000513	0.00276	CcSEcCtD
Phenelzine—Malaise—Mycophenolic acid—systemic scleroderma	0.00051	0.00274	CcSEcCtD
Phenelzine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000507	0.00272	CcSEcCtD
Phenelzine—Fatigue—Captopril—systemic scleroderma	0.000506	0.00272	CcSEcCtD
Phenelzine—Anxiety—Leflunomide—systemic scleroderma	0.000503	0.00271	CcSEcCtD
Phenelzine—Constipation—Captopril—systemic scleroderma	0.000502	0.0027	CcSEcCtD
Phenelzine—Discomfort—Leflunomide—systemic scleroderma	0.000499	0.00268	CcSEcCtD
Phenelzine—Nervousness—Lisinopril—systemic scleroderma	0.000495	0.00266	CcSEcCtD
Phenelzine—Dry mouth—Leflunomide—systemic scleroderma	0.000494	0.00266	CcSEcCtD
Phenelzine—Vomiting—Pentoxifylline—systemic scleroderma	0.000493	0.00265	CcSEcCtD
Phenelzine—Psychotic disorder—Prednisone—systemic scleroderma	0.000491	0.00264	CcSEcCtD
Phenelzine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00049	0.00264	CcSEcCtD
Phenelzine—CYP3A5—lung—systemic scleroderma	0.000489	0.0099	CbGeAlD
Phenelzine—Rash—Pentoxifylline—systemic scleroderma	0.000489	0.00263	CcSEcCtD
Phenelzine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000488	0.00263	CcSEcCtD
Phenelzine—Headache—Pentoxifylline—systemic scleroderma	0.000486	0.00261	CcSEcCtD
Phenelzine—Feeling abnormal—Captopril—systemic scleroderma	0.000484	0.0026	CcSEcCtD
Phenelzine—Vision blurred—Lisinopril—systemic scleroderma	0.00048	0.00258	CcSEcCtD
Phenelzine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00048	0.00258	CcSEcCtD
Phenelzine—Asthenia—Mometasone—systemic scleroderma	0.00048	0.00258	CcSEcCtD
Phenelzine—Tremor—Lisinopril—systemic scleroderma	0.000478	0.00257	CcSEcCtD
Phenelzine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000476	0.00256	CcSEcCtD
Phenelzine—Pruritus—Mometasone—systemic scleroderma	0.000473	0.00254	CcSEcCtD
Phenelzine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000473	0.00254	CcSEcCtD
Phenelzine—Tachycardia—Leflunomide—systemic scleroderma	0.000473	0.00254	CcSEcCtD
Phenelzine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000471	0.00253	CcSEcCtD
Phenelzine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000468	0.00252	CcSEcCtD
Phenelzine—Body temperature increased—Captopril—systemic scleroderma	0.000464	0.0025	CcSEcCtD
Phenelzine—Oedema—Mycophenolic acid—systemic scleroderma	0.000462	0.00248	CcSEcCtD
Phenelzine—Nausea—Pentoxifylline—systemic scleroderma	0.00046	0.00248	CcSEcCtD
Phenelzine—Malaise—Lisinopril—systemic scleroderma	0.00046	0.00247	CcSEcCtD
Phenelzine—Leukopenia—Lisinopril—systemic scleroderma	0.000456	0.00245	CcSEcCtD
Phenelzine—CYP2E1—lung—systemic scleroderma	0.000456	0.00924	CbGeAlD
Phenelzine—Shock—Mycophenolic acid—systemic scleroderma	0.000454	0.00244	CcSEcCtD
Phenelzine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000451	0.00242	CcSEcCtD
Phenelzine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000446	0.0024	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000443	0.00238	CcSEcCtD
Phenelzine—CYP3A4—digestive system—systemic scleroderma	0.000439	0.0089	CbGeAlD
Phenelzine—Insomnia—Leflunomide—systemic scleroderma	0.000438	0.00236	CcSEcCtD
Phenelzine—Paraesthesia—Leflunomide—systemic scleroderma	0.000435	0.00234	CcSEcCtD
Phenelzine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00233	CcSEcCtD
Phenelzine—Anxiety—Lisinopril—systemic scleroderma	0.000432	0.00233	CcSEcCtD
Phenelzine—Discomfort—Lisinopril—systemic scleroderma	0.000429	0.00231	CcSEcCtD
Phenelzine—Dyspepsia—Leflunomide—systemic scleroderma	0.000426	0.00229	CcSEcCtD
Phenelzine—Vomiting—Mometasone—systemic scleroderma	0.000425	0.00229	CcSEcCtD
Phenelzine—Dry mouth—Lisinopril—systemic scleroderma	0.000424	0.00228	CcSEcCtD
Phenelzine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000422	0.00227	CcSEcCtD
Phenelzine—Rash—Mometasone—systemic scleroderma	0.000422	0.00227	CcSEcCtD
Phenelzine—Asthenia—Captopril—systemic scleroderma	0.000421	0.00227	CcSEcCtD
Phenelzine—Dermatitis—Mometasone—systemic scleroderma	0.000421	0.00227	CcSEcCtD
Phenelzine—Headache—Mometasone—systemic scleroderma	0.000419	0.00225	CcSEcCtD
Phenelzine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000418	0.00225	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000418	0.00225	CcSEcCtD
Phenelzine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000418	0.00225	CcSEcCtD
Phenelzine—Fatigue—Leflunomide—systemic scleroderma	0.000417	0.00224	CcSEcCtD
Phenelzine—Oedema—Lisinopril—systemic scleroderma	0.000416	0.00224	CcSEcCtD
Phenelzine—Pruritus—Captopril—systemic scleroderma	0.000416	0.00224	CcSEcCtD
Phenelzine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000415	0.00223	CcSEcCtD
Phenelzine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00223	CcSEcCtD
Phenelzine—Constipation—Leflunomide—systemic scleroderma	0.000414	0.00223	CcSEcCtD
Phenelzine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000411	0.00221	CcSEcCtD
Phenelzine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00221	CcSEcCtD
Phenelzine—Shock—Lisinopril—systemic scleroderma	0.000409	0.0022	CcSEcCtD
Phenelzine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000407	0.00219	CcSEcCtD
Phenelzine—Tachycardia—Lisinopril—systemic scleroderma	0.000406	0.00218	CcSEcCtD
Phenelzine—Body temperature increased—Azathioprine—systemic scleroderma	0.000405	0.00218	CcSEcCtD
Phenelzine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000403	0.00217	CcSEcCtD
Phenelzine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000402	0.00216	CcSEcCtD
Phenelzine—Erectile dysfunction—Prednisone—systemic scleroderma	0.0004	0.00215	CcSEcCtD
Phenelzine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.0004	0.00215	CcSEcCtD
Phenelzine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000399	0.00215	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000399	0.00214	CcSEcCtD
Phenelzine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000398	0.00214	CcSEcCtD
Phenelzine—Nausea—Mometasone—systemic scleroderma	0.000397	0.00214	CcSEcCtD
Phenelzine—Weight increased—Prednisone—systemic scleroderma	0.000395	0.00213	CcSEcCtD
Phenelzine—Ataxia—Methotrexate—systemic scleroderma	0.000395	0.00212	CcSEcCtD
Phenelzine—Constipation—Mycophenolic acid—systemic scleroderma	0.000395	0.00212	CcSEcCtD
Phenelzine—Dizziness—Captopril—systemic scleroderma	0.000388	0.00209	CcSEcCtD
Phenelzine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00208	CcSEcCtD
Phenelzine—Body temperature increased—Leflunomide—systemic scleroderma	0.000383	0.00206	CcSEcCtD
Phenelzine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000381	0.00205	CcSEcCtD
Phenelzine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000379	0.00204	CcSEcCtD
Phenelzine—Insomnia—Lisinopril—systemic scleroderma	0.000376	0.00202	CcSEcCtD
Phenelzine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00202	CcSEcCtD
Phenelzine—Paraesthesia—Lisinopril—systemic scleroderma	0.000374	0.00201	CcSEcCtD
Phenelzine—Vomiting—Captopril—systemic scleroderma	0.000373	0.00201	CcSEcCtD
Phenelzine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000372	0.002	CcSEcCtD
Phenelzine—Rash—Captopril—systemic scleroderma	0.00037	0.00199	CcSEcCtD
Phenelzine—Dermatitis—Captopril—systemic scleroderma	0.00037	0.00199	CcSEcCtD
Phenelzine—Somnolence—Lisinopril—systemic scleroderma	0.00037	0.00199	CcSEcCtD
Phenelzine—Headache—Captopril—systemic scleroderma	0.000368	0.00198	CcSEcCtD
Phenelzine—Dyspepsia—Lisinopril—systemic scleroderma	0.000366	0.00197	CcSEcCtD
Phenelzine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000365	0.00196	CcSEcCtD
Phenelzine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000364	0.00196	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000359	0.00193	CcSEcCtD
Phenelzine—Fatigue—Lisinopril—systemic scleroderma	0.000359	0.00193	CcSEcCtD
Phenelzine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00193	CcSEcCtD
Phenelzine—Constipation—Lisinopril—systemic scleroderma	0.000356	0.00191	CcSEcCtD
Phenelzine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00191	CcSEcCtD
Phenelzine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000352	0.0019	CcSEcCtD
Phenelzine—Nausea—Captopril—systemic scleroderma	0.000349	0.00188	CcSEcCtD
Phenelzine—Asthenia—Leflunomide—systemic scleroderma	0.000347	0.00187	CcSEcCtD
Phenelzine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000343	0.00184	CcSEcCtD
Phenelzine—Pruritus—Leflunomide—systemic scleroderma	0.000343	0.00184	CcSEcCtD
Phenelzine—Dizziness—Azathioprine—systemic scleroderma	0.000339	0.00182	CcSEcCtD
Phenelzine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000334	0.0018	CcSEcCtD
Phenelzine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000331	0.00178	CcSEcCtD
Phenelzine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00177	CcSEcCtD
Phenelzine—Body temperature increased—Lisinopril—systemic scleroderma	0.000329	0.00177	CcSEcCtD
Phenelzine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00176	CcSEcCtD
Phenelzine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000327	0.00176	CcSEcCtD
Phenelzine—Vomiting—Azathioprine—systemic scleroderma	0.000326	0.00175	CcSEcCtD
Phenelzine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00174	CcSEcCtD
Phenelzine—Drowsiness—Methotrexate—systemic scleroderma	0.000324	0.00174	CcSEcCtD
Phenelzine—Rash—Azathioprine—systemic scleroderma	0.000323	0.00174	CcSEcCtD
Phenelzine—Dermatitis—Azathioprine—systemic scleroderma	0.000323	0.00174	CcSEcCtD
Phenelzine—Headache—Azathioprine—systemic scleroderma	0.000321	0.00173	CcSEcCtD
Phenelzine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00173	CcSEcCtD
Phenelzine—Dizziness—Leflunomide—systemic scleroderma	0.00032	0.00172	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00169	CcSEcCtD
Phenelzine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000312	0.00168	CcSEcCtD
Phenelzine—Sweating—Methotrexate—systemic scleroderma	0.00031	0.00167	CcSEcCtD
Phenelzine—Vomiting—Leflunomide—systemic scleroderma	0.000308	0.00166	CcSEcCtD
Phenelzine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000305	0.00164	CcSEcCtD
Phenelzine—Rash—Leflunomide—systemic scleroderma	0.000305	0.00164	CcSEcCtD
Phenelzine—Dermatitis—Leflunomide—systemic scleroderma	0.000305	0.00164	CcSEcCtD
Phenelzine—Nausea—Azathioprine—systemic scleroderma	0.000305	0.00164	CcSEcCtD
Phenelzine—Headache—Leflunomide—systemic scleroderma	0.000303	0.00163	CcSEcCtD
Phenelzine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0003	0.00162	CcSEcCtD
Phenelzine—Asthenia—Lisinopril—systemic scleroderma	0.000298	0.00161	CcSEcCtD
Phenelzine—Pruritus—Lisinopril—systemic scleroderma	0.000294	0.00158	CcSEcCtD
Phenelzine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000294	0.00158	CcSEcCtD
Phenelzine—Rash—Mycophenolic acid—systemic scleroderma	0.000291	0.00157	CcSEcCtD
Phenelzine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000291	0.00156	CcSEcCtD
Phenelzine—Headache—Mycophenolic acid—systemic scleroderma	0.000289	0.00156	CcSEcCtD
Phenelzine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00155	CcSEcCtD
Phenelzine—Nausea—Leflunomide—systemic scleroderma	0.000288	0.00155	CcSEcCtD
Phenelzine—Vision blurred—Prednisone—systemic scleroderma	0.000285	0.00153	CcSEcCtD
Phenelzine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000281	0.00151	CcSEcCtD
Phenelzine—Agitation—Prednisone—systemic scleroderma	0.000278	0.0015	CcSEcCtD
Phenelzine—Dizziness—Lisinopril—systemic scleroderma	0.000275	0.00148	CcSEcCtD
Phenelzine—Nausea—Mycophenolic acid—systemic scleroderma	0.000274	0.00148	CcSEcCtD
Phenelzine—Malaise—Prednisone—systemic scleroderma	0.000273	0.00147	CcSEcCtD
Phenelzine—Vomiting—Lisinopril—systemic scleroderma	0.000264	0.00142	CcSEcCtD
Phenelzine—Rash—Lisinopril—systemic scleroderma	0.000262	0.00141	CcSEcCtD
Phenelzine—Convulsion—Prednisone—systemic scleroderma	0.000262	0.00141	CcSEcCtD
Phenelzine—Dermatitis—Lisinopril—systemic scleroderma	0.000262	0.00141	CcSEcCtD
Phenelzine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00141	CcSEcCtD
Phenelzine—Headache—Lisinopril—systemic scleroderma	0.000261	0.0014	CcSEcCtD
Phenelzine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00139	CcSEcCtD
Phenelzine—Anxiety—Prednisone—systemic scleroderma	0.000257	0.00138	CcSEcCtD
Phenelzine—Discomfort—Prednisone—systemic scleroderma	0.000255	0.00137	CcSEcCtD
Phenelzine—Nausea—Lisinopril—systemic scleroderma	0.000247	0.00133	CcSEcCtD
Phenelzine—Oedema—Prednisone—systemic scleroderma	0.000247	0.00133	CcSEcCtD
Phenelzine—Shock—Prednisone—systemic scleroderma	0.000243	0.00131	CcSEcCtD
Phenelzine—Tachycardia—Prednisone—systemic scleroderma	0.000241	0.0013	CcSEcCtD
Phenelzine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000241	0.0013	CcSEcCtD
Phenelzine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000239	0.00128	CcSEcCtD
Phenelzine—Vision blurred—Methotrexate—systemic scleroderma	0.000238	0.00128	CcSEcCtD
Phenelzine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000235	0.00126	CcSEcCtD
Phenelzine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00125	CcSEcCtD
Phenelzine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00124	CcSEcCtD
Phenelzine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00123	CcSEcCtD
Phenelzine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00123	CcSEcCtD
Phenelzine—Malaise—Methotrexate—systemic scleroderma	0.000228	0.00123	CcSEcCtD
Phenelzine—Leukopenia—Methotrexate—systemic scleroderma	0.000226	0.00122	CcSEcCtD
Phenelzine—Insomnia—Prednisone—systemic scleroderma	0.000223	0.0012	CcSEcCtD
Phenelzine—Paraesthesia—Prednisone—systemic scleroderma	0.000222	0.00119	CcSEcCtD
Phenelzine—Convulsion—Methotrexate—systemic scleroderma	0.000219	0.00118	CcSEcCtD
Phenelzine—Dyspepsia—Prednisone—systemic scleroderma	0.000217	0.00117	CcSEcCtD
Phenelzine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00116	CcSEcCtD
Phenelzine—Fatigue—Prednisone—systemic scleroderma	0.000213	0.00115	CcSEcCtD
Phenelzine—Discomfort—Methotrexate—systemic scleroderma	0.000213	0.00114	CcSEcCtD
Phenelzine—Constipation—Prednisone—systemic scleroderma	0.000211	0.00114	CcSEcCtD
Phenelzine—Feeling abnormal—Prednisone—systemic scleroderma	0.000204	0.00109	CcSEcCtD
Phenelzine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.0002	0.00107	CcSEcCtD
Phenelzine—Body temperature increased—Prednisone—systemic scleroderma	0.000195	0.00105	CcSEcCtD
Phenelzine—Insomnia—Methotrexate—systemic scleroderma	0.000187	0.001	CcSEcCtD
Phenelzine—Paraesthesia—Methotrexate—systemic scleroderma	0.000185	0.000997	CcSEcCtD
Phenelzine—Somnolence—Methotrexate—systemic scleroderma	0.000184	0.000987	CcSEcCtD
Phenelzine—Dyspepsia—Methotrexate—systemic scleroderma	0.000182	0.000978	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000178	0.000959	CcSEcCtD
Phenelzine—Fatigue—Methotrexate—systemic scleroderma	0.000178	0.000957	CcSEcCtD
Phenelzine—Asthenia—Prednisone—systemic scleroderma	0.000177	0.000953	CcSEcCtD
Phenelzine—Pruritus—Prednisone—systemic scleroderma	0.000175	0.00094	CcSEcCtD
Phenelzine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00017	0.000915	CcSEcCtD
Phenelzine—Dizziness—Prednisone—systemic scleroderma	0.000163	0.000879	CcSEcCtD
Phenelzine—Body temperature increased—Methotrexate—systemic scleroderma	0.000163	0.000878	CcSEcCtD
Phenelzine—Vomiting—Prednisone—systemic scleroderma	0.000157	0.000845	CcSEcCtD
Phenelzine—Rash—Prednisone—systemic scleroderma	0.000156	0.000838	CcSEcCtD
Phenelzine—Dermatitis—Prednisone—systemic scleroderma	0.000156	0.000837	CcSEcCtD
Phenelzine—Headache—Prednisone—systemic scleroderma	0.000155	0.000832	CcSEcCtD
Phenelzine—Asthenia—Methotrexate—systemic scleroderma	0.000148	0.000797	CcSEcCtD
Phenelzine—Nausea—Prednisone—systemic scleroderma	0.000147	0.000789	CcSEcCtD
Phenelzine—Pruritus—Methotrexate—systemic scleroderma	0.000146	0.000786	CcSEcCtD
Phenelzine—Dizziness—Methotrexate—systemic scleroderma	0.000137	0.000734	CcSEcCtD
Phenelzine—Vomiting—Methotrexate—systemic scleroderma	0.000131	0.000706	CcSEcCtD
Phenelzine—Rash—Methotrexate—systemic scleroderma	0.00013	0.0007	CcSEcCtD
Phenelzine—Dermatitis—Methotrexate—systemic scleroderma	0.00013	0.0007	CcSEcCtD
Phenelzine—Headache—Methotrexate—systemic scleroderma	0.000129	0.000696	CcSEcCtD
Phenelzine—Nausea—Methotrexate—systemic scleroderma	0.000123	0.00066	CcSEcCtD
